Curriculum vitae

CURRICULUM VITAE
PERSONAL DATA
Alexandria, Egypt (United States Citizen) 9 Alsace Court Little Rock, Arkansas 72223 (501) 821-4562 BUSINESS ADDRESS: University of Arkansas for Medical Sciences Department of Surgery Division of Vascular Surgery 4301 W. Markham, Slot 520-2 Little Rock, Arkansas 72205 (501) 257-6864 PROFESSIONAL EXPERIENCE
University of Arkansas for Medical Sciences University of Arkansas for Medical Sciences University of Arkansas for Medical Sciences Central Arkansas Veterans Healthcare System Central Arkansas Veterans Healthcare System Central Arkansas Veterans Healthcare System EDUCATIONAL BACKGROUND
University of Michigan Medical School Ann Arbor, Michigan M.D. University of Michigan Ann Arbor, Michigan B.S., Human Physiology POST- GRADUATE TRAINING
Internship, Department of Surgery University of Michigan Medical Center Ann Arbor, Michigan Resident, General Surgery University of Michigan Medical Center Ann Arbor, Michigan Chief Resident, General Surgery University of Michigan Medical Center Ann Arbor, Michigan Research Fellow, National Institutes of Health Departments of Physiology & Surgery Cardiovascular Laboratory University of Michigan Medical Center Ann Arbor, Michigan Senior Investigators: Louis G. D’Alecy, D.M.D., Ph.D. Gerald B. Zelenock, M.D. Surgical Critical Care Fellow University of Michigan Medical Center Ann Arbor, Michigan Vascular Surgery Fellow University of Michigan Medical Center Ann Arbor, Michigan LICENSURE AND CERTIFICATION
Recertification, American Board of Surgery – Added Qualifications in General/Vascular Surgery (Certificate #100709) Recertification, American Board of Surgery (Certificate #39169) Diplomat, National Board of Medical Examiners State of Michigan Medical License (No. 4301051522) American Board of Surgery (Certificate #39169) State of Arkansas Medical License (No. E-0588) American Board of Surgery – Added Qualifications In General/Vascular Surgery (Certificate #100709) Basic Cardiac Life Support Advanced Cardiac Life Support Advanced Trauma Life Support RESEARCH SUPPORT
Basic Science
Research Fellow, American Heart Association of Michigan (Summers) National Research Service Award National Institutes of Health # 1 32 HL08243-01 “Infrarenal aortic clamping: renal effects and adenosine” Hornick Endowment for Research (UAMS) “Stroke and Related Disorders” $15,000 (One Time Award) American Heart Association Grant-In-Aid #9810017AR “The Role of Homocysteine and Hypertension on Intimal Hyperplasia in a Rat Carotid Endarterectomy Model” $60,000 (2 yr Award) Hornick Endowment Award for Cerebrovascular Research (UAMS) “Cellular and Clinical Investigation of the Role of Homocysteine in Cerebrovascular Disease” $90,182 (2 yr Award) Merit Review Grant Central Arkansas Veterans Healthcare System “Pathogenesis of Homocysteine-Mediated Hyperplastic Response” $425,700 (3 yr award) Merck KGaA “An Investigation of Saratin, a specific inhibitor of platelet to collagen adhesion and its effects on platelet aggregation, thrombus formation and neointimal hyperplasia in a rat carotid endarterectomy model” $253,480 (2 yr award) UAMS Tobacco Settlement Fund “Cigarette Smoking Increases Intimal Hyperplasia Development Following Carotid Endarterectomy” $79,512 Merit Review Grant Central Arkansas Veterans Healthcare System “Pathogenesis of Homocysteine-Mediated Hyperplastic Response” $597,700 (4 yr award) Clinical Science
“North American Symptomatic Carotid Endarterectomy Trial (NASCET)” National Institute of Health July 1991 Co-Investigator “Oral Anticoagulant Therapy to Improve Patency of Small Caliber Prosthetic Bypass Grafts” (VA CSP #362) October 1991 Co-Investigator “Aneurysm Detection and Management Study (ADAM)” (VA CSP #379) April 1992 Co-Investigator “Aspirin and Carotid Endarterectomy (ACE)” Clinical Science
National Institute of Health August 1994 Co-Investigator “The Use of Diaspirin Cross-Linked Hemoglobin for the Avoidance or Reduction of Perioperative Blood Transfusions” Baxter Healthcare Corporation January 1997 Co-Investigator “One Year Randomized Double Blind Placebo Controlled Multicenter Study Comparing the Efficacy of 10mg and 80mg Atorvastatin in Patients With Peripheral Vascular Disease” Parke-Davis July 1997 Co-Investigator “Mivazerol: A Potential Agent for the Prevention of Perioperative Cardiac Morbidity and Mortality” UCB Pharma, Inc. September 1997 Principal Investigator “A Phase III, Randomized, Controlled, Open-Label, Multi-Center, Parallel Group Study Designed to Evaluate the Safety and Efficacy of Poly SFH-P Injection in the Total Elimination of Allogenic Red Cell Transfusion” Northfield Laboratories, Inc. December 1998 Principal Investigator “A Prospective Randomized Trial of Reduction of Body Iron Stores on Vascular Disease Outcomes in Atherosclerotic Peripheral Vascular Disease (FeAST)” (VA CSP #410) February 1999 Principal Investigator “Coronary Artery Revascularization Prophylaxis (CARP) Trial” (VA CSP #411) March 1999 Principal Investigator “A Phase III Dose Escalation Study to Evaluate Safety and Efficacy for the Prevention and/or Amelioration of Acute Renal Impairment Who are Undergoing Elective Cardiovascular Surgical Procedures In U.S. Sites” Pharmacia Upjohn, Inc. March 1999 Principal Investigator “Therapeutic Angiogenesis with FGS for Intermittent Claudication” Chiron, Corp. June 1999 Co-Investigator “Coronary Artery Bypass Endarterectomy Staging Trial (CABEST) National Institute of Health October 1999 Principal Investigator “A Randomized, Double-Blind, Multi-Center, Comparative Phase III Study of Intravenous BMS-284756 With or Without Oral BMS-284756 Follow-Up Versus Intravenous Piperacillin/Tazobactam With or Without Oral Amoxicillin/Clavulanate Follow-Up in the Treatment Of Complicated Clinical Science
Skin and Skin Structure Infections” Bristol-Meyers Squibb 2001 Principal Investigator “A Randomized, Double-Blinded, Parallel-Group, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy of Safety of Repifermin (KGF-2) in Subjects with Venous Ulcers” Human Genome Sciences 2001 Principal Investigator “A Double-Blind, Randomized, Placebo-Controlled Study to Assess the Efficacy and Safety of Circulase for the Treatment of Critical Leg Ischemia” Catalyst 2001 Principal Investigator Welfide International Corp. “A Double-Blind, Randomized, Placebo-Controlled Study to Assess the Efficacy and Safety of Circulase in Conjunction with Peripheral Revascularization for the Treatment Of Critical Leg Ischemia” Catalyst 2001 Principal Investigator “Linezolid IV or PO Compared to Unasyn IV or Augmentin PO for the Treatment of Patients with Diabetic Foot Infections – A Randomized, Open-Label, Phase IV Clinical Trial” Pharmacia 2001 Principal Investigator “A Double-Blind, Placebo-Controlled, Parallel Group Study of the Effects of Zoniporide on Perioperative Cardiac Events in High Risk Subjects Undergoing Noncardiac Vascular Surgery” Pfizer 2001 Co-Investigator “A Phase III, Multicenter Study to Determine the Safety and Efficacy of MS-325-Enhanced MRA in Patients with Known or Suspected Renal Arterial Disease” EPIX Medical, Inc. 2002 Principal Investigator “A Phase III, Multicenter, Randomized, Double-Blind Placebo-Controlled Trial of the Ex-Vivo Treatment with CGT003 of Peripheral Vein Grafts in Patients Undergoing Peripheral Arterial Bypass Grafts” Protocol CGT003-03 Corgentech, Inc. 2002 Co-Investigator “Open Versus Endovascular Repair (OVER) of Abdominal Aortic Aneurysms Trial. VACSP #498 2002 Clinical Science
“A Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study to Investigate Safety, Pharmacokinetics and Pharmacodynamics of Different Doses (0.2, 0.6, 2.0, and 20.0mg/hr) of BIWH3 Administered for 6 hours in patients with Chronic Limb Ischemia (CLI Fontaine Class III or IV)” COINART 2002 Principal Investigator “Effect of Clopidogrel vs. Placebo, on a Background of Standard Care Including Aspirin in Maintaining the Patency of Lower Limb Arteries After Angioplasty” (CAMPER Study) Protocol #EIV 7920 Sanofi-Synthelabs, Inc. Bristol-Myers Squibb July 2003 Principal Investigator “Catheter-Directed Intrathrombus Thrombolysis with Urokinase and Anticoagulation versus Anticoagulation Alone for Acute Iliofemoral Venous Thrombosis: A Multicenter, Randomized Trial (Toledo Study)” Jobst Vascular Center of the Toledo Hospital December 2003 Co-Investigator “A Phase III, Randomized, Open-Label, Multicenter Study to Evaluate the Safety and Efficacy of Dalbavancin versus Vancomycin in the Treatment of Skin and Soft Tissue Infections with Suspected or Confirmed Methicillin Resistant Staphylococcus Aureus (MRSA)” Vicuron Pharmaceuticals, Inc. December 2003 Principal Investigator “A Phase II Double-Blind, Randomized, Placebo-Controlled Study to Assess the Safety and Efficacy of AMG0001 to Improve Perfusion in Critical Leg Ischemia” Anges Pharmaceuticals January 2004 Principal Investigator Cubicin for Post-Surgical Wound Infections Cubist Pharmaceuticals January 2004 Co-Investigator “A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase III Study of Rosuvastatin (Crestor) 20mg in the Primary Prevention of Cardiovascular Events Among Subjects with Low Levels of LDL-Cholesterol and Elevated Levels of C-Reactive Protein” Astra Zeneca Pharmaceuticals December, 2004 Principal Investigator “Phase 3, Multicenter, Multinational, Randomized, Partial Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Alfimeprase in Subjects with Acute Peripheral Arterial Occlusion” Nuvelo, Inc. March, 2005 Principal Investigator “Carotid Revascularization Endarterectomy vs. Stenting Trial” Clinical Science
National Institute of Neurological Disorders and Stroke and National Institutes of Health June, 2005 Sub-Investigator “A Phase 3, Randomized, Double-Blind, Multinational Trial of Intravenous Telavancin Versus Vancomycin for Treatment of Complicated Gram-positive Skin and Skin Structure Infections with a Focus on Patients with Infections Due to Methicillin-resistant Staphylococcus aureus” Theravance, Inc. July, 2005 Principal Investigator “A Phase II Multi-Center, Randomized, Double-Blind, Placebo Controlled Trial of VLTS-934 in Subjects with Intermittent Claudication Secondary to Peripheral Arterial Disease” Valentis, Inc. August, 2005 Principal Investigator “Positive Impact of Endovascular Options for Treating Aneurysms Early” Medtronic/The Cleveland Clinic Foundation May, 2006 Sub-Investigator A Two-Part, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Simvastatin, Losartan and Pioglitazone on Cardiovascular Disease Biomarkers in Lower Extremity Atherosclerotic Plaque Excised from Patients with Peripheral Arterial Disease FoxHollow April 2006 Sub Investigator Claudication: Exercise Vs. Endoluminal Revascularization NIH, National Heart Lung and Blood Institute October 2006 Principal Investigator Evaluation of FM220 in Patients With Peripheral Arterial Disease (PAD) FlowMedic May 2007 Principal Investigator A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of SCH 530348 in Addition to Standard of Care in Subjects With a History of Atherosclerotic Disease: Thrombin Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events (TRA 2°P-TIMI 50) Schering-Plough Research Institute June 2008 Principal Investigator Vascutek Anaconda Stent Graft System Phase II IDE Terumo Cardiovascular December, 2008 Principal Investigator Evaluation of Cilostazol in Combination with L-Carnitine in Subjects with Intermittent Claudication (ECLECTIC) Clinical Science
Colorado Prevention Center November, 2008 Principal Investigator A Phase IIa Multicenter, Randomized, Double-Blind, Placebo-and Active Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of K-134 for the Treatment of Intermittent Claudication Kowa Research Institute March, 2009 Principal Investigator VA Cooperative Study #474: Radial Artery Vs. Saphenous Vein Grafts in Coronary Bypass Surgery VA Cooperative Studies Program April, 2009 Principal Investigator MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia (CLI) in Subjects with Severe Peripheral Arterial Disease (PAD) Biomet Biologics February, 2010 Sub Investigator Comparison of Safety and Primary Patency Between FUSION Vascular Graft, FUSION Vascular Graft with Bioline, and EXXCEL Soft ePTFE (FINEST) Maquet Cardiovascular July, 2010 Principal Investigator A Multicentre, Randomised, Double-Blind, Placebo-Controlled Phase IV Trial to Evaluate the Effect of Saxagliptin on the Incidence of Cardiovascular Death, Myocardial Infarction or Ischaemic Stroke in Patients with Type 2 Diabetes (SAVOR TIMI-53) Astra Zeneca September, 2010 Principal Investigator A Pivotal Clinical Study to Evaluate the Safety and Effectiveness of the TriVascular AAA Stent Graft System Trivascular Inc August, 2010 Sub-Investigator PROFESSIONAL SOCIETIES
American Association for Vascular Surgery (Distinguished Fellow)
Fellow, American College of Surgeons
Association for Academic Surgery
Southwestern Surgical Congress
National Association of VA Physicians & Dentists
Southern Association for Vascular Surgery
Association of VA Surgeons
TEACHING ACTIVITIES
Mountain Home Primary Care Clinic Providers “Review on Vascular Disease” 20th Annual Family Practice Intensive Review “Update: Carotid Artery Disease & Stroke Prevention” Moderator – M & M Conference at UAMS/VA Director of Medical Student Education for VA Surgery Rotation Presentation to Ambulatory Care Providers on Vascular Disease Interphase (Teaching 2nd year Medical Students) Surgical Critical Care Fellow Lecture Series Mini Workshop – Southwestern Surgical Congress Meeting “Modern Management of Complications Following Arteriography” HONORS AND AWARDS
B.S. Degree with Highest Honors in Human Physiology University of Michigan Ann Arbor, Michigan American Heart Association of Michigan Outstanding Student Research Fellow Alpha Omega Alpha Honor Society University of Michigan Medical School Ann Arbor, Michigan University of Michigan Medical School, Ann Arbor, Michigan Dean’s Award for Research Excellence for Outstanding Research in Medical School University of Michigan Medical School Ann Arbor, Michigan C. Gardner Child 3rd Award for Outstanding Student Clerkship, Elective & Research, Department of Surgery University of Michigan Medical School Ann Arbor, Michigan House Officer of the Month (July) Ann Arbor, Michigan Veterans Hospital Founder’s Award (Best Paper @ Annual Meeting) Southern Association for Vascular Surgery Outstanding Teaching Attending from UAMS Surgical residents Resident’s Award (Best Paper @ Annual Meeting) HONORS AND AWARDS
Jack A. Barney Resident’s Award. Southwestern Surgical Congress Founder’s Award (Best Paper @ Annual Meeting) Southern Association for Vascular Surgery Third best presentation 4th Conference on Hyperhomocysteinemia Outstanding Teaching Attending from UAMS Medical Students and Surgical Residents Founder’s Award (Best Paper @ Annual Meeting) Southern Association for Vascular Surgery ADMINISTRATION
Operating Room Management Council Chairman Central Arkansas Veterans Healthcare System Little Rock, Arkansas National VA Standardization Surgery User Group Veteran’s Health Administration Clinical Practice Guidelines for the Management of Chronic Renal Disease and Pre-ESRD in the Primary Care Setting Peer Reviewer for Scientific Journals Journal of Vascular Surgery American Journal of Surgery VISN 16 Surgical Subcommittee of the Tertiary Care Committee Veterans Healthcare System National Task Force for Vascular Surgery Veterans Healthcare System Operating Room Management Council Central Arkansas Veterans Healthcare System Human Research Advisory Committee University of Arkansas for Medical Sciences Little Rock, Arkansas Medical School Admission Interviewer University of Arkansas for Medical Sciences Little Rock, Arkansas Student Promotion Committee, Class of 2000 University of Arkansas for Medical Sciences Little Rock, Arkansas Central Arkansas Veterans Healthcare System Little Rock, Arkansas Medical Director, Peripheral Vascular Laboratory Central Arkansas Veterans Healthcare System Little Rock, Arkansas Chief, Vascular Surgery Central Arkansas Veterans Healthcare System Little Rock, Arkansas ABSTRACTS AND PRESENTATIONS
1. Moursi MM, Luyckx BA, D’Alecy LG. The role of ethanol in diluents of drugs that protect the
hypoxic brain. (Abstract) Fed Proc 1992; 41:1619. 2. Moursi MM, D’Alecy LG. Phenylephrine induced changes in cerebral blood flow and EEG
patterns in the conscious dog. Read before the American Heart Association of Michigan Forum. Lansing, Michigan. September 1984. 3. Moursi MM, D’Alecy LG. Regional blood flow changes in response to mildly pressor doses of
triglycyl desamino lysine and arginine vasopressin in the conscious dog. (Abstract) Fed Proc 1984; 43:1082. 4. Moursi MM, D’Alecy LG. Depressor response during experimental splanchnic portal vein
hypertension in the dog. (Abstract) Fed Proc 1984; 43:695. 5. Moursi MM, Rising CL, Zelenock GB, D’Alecy LG. Dextrose administration exacerbates acute
Renal ischemic damage in anesthetized dogs. Read before the University of Michigan Medical School Medical Student Research Forum. Ann Arbor, Michigan, February 1986. 6. Moursi MM, Zelenock GD, D’Alecy LG. The course of hypertension induced by infrarenal aortic
cross-clamping in the dog. Read before the University of Michigan Department of Surgery Mayo Lecture Day. Ann Arbor, Michigan. February 1991. 7. Moursi MM, Zelenock GD, D’Alecy LG. Continuous pressure monitoring excludes a direct
mechanical cause for hypertension during infrarenal aortic cross-clamping in the dog. Read before the Michigan Chapter of the American College of Surgeons. Lansing, Michigan. May 1991. 8. Moursi MM, Zelenock GD, D’Alecy LG. Delayed onset hypertension during infrarenal aortic
cross-clamping in dogs: Implications for antihypertensive management. Read before the Collier Medical Society Research Conference. Traverse City, Michigan. October 1991. 9. Moursi MM, Beebe HG, Messina LM, Stanley JC. Aortic Aneurysm Retardation in the
Propranalol Treated Blotchy Mouse Appears Related to Hemodynamic Alterations Independent of Lysyl Oxidase Activity. Read before the Midwestern Vascular Surgical Society. Cincinnati, Ohio. September 1994. 10. Barone GW, Eidt JF, Moursi MM, Barnes RW, Gemmett SM, Cruz N Jr. A Review of
Anaphylactoid Reactions to Protamine and Possible Management. Read before the Society for Clinical Vascular Surgery, Naples, Florida. March 1997. 11. Proctor MC, Greenfield LJ, Cho KJ, Moursi MM, James EA. Assessment of Vena Caval
Penetration. Read before the Radiological Society of North America. Chicago, Illinois. December 1996. 12. Anderson WJ, Proctor MC, Greenfield LJ, Moursi MM. Apparent Vena Caval Penetration by the
Greenfield Filter. Read before the Society of Cardiovascular and Interventional Radiology Conference. Washington DC. March 1997. 13. Southern FN, Cruz N Jr, Fink LM, Eidt JF, Moursi MM. Hyperhomocysteinemia Increases Intimal
Hyperplasia in a Rat Carotid Endarterectomy Model. Read before the Southern Association for Vascular Surgery. Rio Grande, Puerto Rico. January 1998. 14. Southern FN, Eidt JF, Barnes RW, Barone GW, Alberty BL, Moursi MM. Thrombosis and
Infection in Aorto-Femoral Bypass Grafts. Read before the Southern Association for Vascular Surgery. Naples, Florida. January 1999. 15. Moursi MM, West B, Drouilhet JC, Read RC. Incisional Hernia after aortic surgery. Read before
the American Hernia Society. Las Vegas, Nevada. January 1999. 16. Saucedo JF, Brown-Alrich LC, Broussard P, McKee J, Eidt JF, Moursi MM, Calandro V, Puri S,
Talley JD. Vascular Complications Using the Angioseal Arterial Closure Device in an Academic Institution. Transcatheter Cardiovascular Therapeutics 11th Annual Symposium. Washington DC. September 1999. 17. Drouilhet JC, Cruz N Jr, Southern FN, Moursi MM, Eidt JF, Barnes RW. The Natural History of
the Contralateral Carotid Artery after Ipsilateral Carotid Endarterectomy. Read before the Southern Association for Vascular Surgery. Tucson, Arizona. January 2000. 18. Cruz CP, Eidt JF, Drouilhet JC, Brown AT, Moursi MM. Saratin: (A Specific Inhibitor of Platelet
to Collagen Adhesion) Decreases Platelet Aggregation and Neointimal Hyperplasia in a Rat Carotid Endarterectomy Model. Founder’s Award, Read before the Southern Association for Vascular Surgery. Tucson, Arizona. January 2000. 19. Cruz CP, Southern FN, Eidt JF, Barnes RW, Moursi MM. Abdominal Aortic Aneurysm Repair.
Society for Clinical Vascular Surgery. Read before the Rancho Mirage, California. March 2000. 20. Allen R, Eidt JF, Barnes RW, Moursi MM, Nix ML, Crawford M. Surgery Rodeo: A Dynamic Tool
to Maintain Teacher Competence. Read before the Southern Group on Educational Affairs. Richmond, Virginia. March 2000. 21. Smith TP, Cruz CP, Brown AT, Eidt JF, Moursi MM. Folate Supplementation Inhibits Intimal
Hyperplasia Induced by a High Homocysteine Diet in a Rat Carotid Endarterectomy Model. Read before the Southern Association for Vascular Surgery. Puerto Rico. January 2001. 22. Smith TP, Cruz CP, Moursi MM, Eidt JF. Infectious Complications Resulting from the Use of the
Perclose Prostar and Techstar Devices. Read before the Southwestern Surgical Congress. Cancun, Mexico. April 2001. 23. Culp WC, McCowan TC, James CA, Marchett WJ, Schmidt MB, Moursi MM, Roberson P.
Microbubble Augmented Ultrasound Declotting of Thrombosed Dialysis Grafts: An Ultrasound Dosage Study in Dogs. Read before the Society of Cardiovascular and Interventional Radiology. Baltimore, Maryland. April 2001. 24. Smith TP, Cruz CP, Brown AT, Eidt JF, Moursi MM. Intimal Hyperplasia Following Carotid
Endarterectomy in an Insulin-Resistant Rat Model. Read before the Association for Academic Surgery. Milwaukee, Wisconsin. November 2001. 25. Smith TP, AlShafie TA, Brown AT, Cruz CP, Eidt JF, Moursi MM. Saratin, an Inhibitor of
Collagen-Platelet Interaction, Decreases Venous Anastomotic Intimal Hyperplasia in a Canine Dialysis Access Model. Read before the Southern Association for Vascular Surgery. Miami Beach, FL. January 2002. 26. Alshafie TA, Brown AT, Eidt JF, Wang Y, Poirier LA, Moursi MM. The effect of gender, estrus
status and plasma homocysteine on intimal hyperplasia after a rat carotid endarterectomy. Experimental Biology, San Diego, CA, April 2003. 27. Fitzgerald RT, Qureshi I, Brown AT, Wang Y, Eidt JF, Poirier LA, Moursi MM. Homocysteine
increases endothelial proliferation and replication via N-methyl D-aspartate receptors. Experimental Biology, San Diego, CA, April 2003. 28. Davis JA, Brown AT, Chen H, Wang Y, Eidt JF, Cruz CP, Moursi MM. Folate decreases intimal
hyperplasia in cigarette smoke exposed rats post-carotid endarterectomy (CEA). Resident Award Session. Read before the Association for Academic Surgeons. Sacramento, CA, November 2003. 29. Cruz CP, Eidt JF, Capps C, Kirtley L, Moursi MM. Major Lower Extremity Amputations at a VA
Hospital: A Seven Year Experience. Read before the Association of VA Surgeons. Nashville, Tennessee, April 2003. 30. Cruz CP, Moursi MM. Effect of Chewing Tobacco Increases Serum Vitamin K Levels and Delays
the Effect of Coumadin in Rats. Read before the Southern Association for Vascular Surgery. Rio Grande, Puerto Rico, January 2004. 31. Bledsoe SL, Brown AT, Davis JA, Chen H, Eidt JF, Moursi MM. Effect of clopidogrel on platelet
aggregation and intimal hyperplasia following carotid endarterectomy in the rat. Read before the 26th World Congress of the International Society for Cardiovascular Surgery. Maui, Hawaii, March 2004. 32. Davis J, Moursi MM. Saratin (An Inhibitor of Platelet-Collagen Interaction) Decreases Platelet
Aggregation and Homocysteine Mediated Post Carotid Endarterectomy Intimal Hyperplasia.
Read before the Southwestern Surgical Congress. Montery, CA, April 2004. Received Jack A.
Barney Resident’s Award.
33. Eidt JF, Moursi MM. Selective Sigmoid Portosystemic Shunt in the Treatment of Lower GI
Bleeding: A Novel Portal Decompression Procedure for Massive Sigmoid Varices. Read before the Southwestern Surgical Congress. Montery, CA, April 2004. 34. Chen H, Brown A, Wu Y, Eidt JF, Moursi MM. Identification of the NMDA Receptor in Rat
Peripheral Vascular Cells. Experimental Biology, Washington DC, April 2004. 35. Kazi R, Brown AT, Chen H, Moursi MM. Locating N-methyl D-aspartate receptors in endothelial
and smooth muscle cell lines. Regional Science Fair-Little Rock, AR. 2003. Received the Arkansas Science and Engineering Fair Institute Educational Talent Search Program Award. 36. Kazi R, Brown A, Chen H, Moursi M. Locating N-methyl D-aspartate receptors in endothelial and
smooth muscle cell lines. Little Rock Central High School Science Fair-Little Rock, AR; December 2003. Received Biochemistry 1st place award. 37. Kazi R, Brown A, Chen H, Moursi M. Locating N-methyl D-aspartate receptors in endothelial and
smooth muscle cell lines. University of Arkansas at Little Rock, Regional Science Fair-Little Rock, AR; February 2004. Received Biochemistry 2nd place award. 38. Kazi R, Brown A, Chen H, Moursi M. Locating N-methyl D-aspartate receptors in endothelial and
smooth muscle cell lines. University of Central Arkansas, State Science Fair-Conway, AR; April 2004. Received Biochemistry 3rd place award. 39. Kazi R, Brown A, Chen H, Moursi M. Locating N-methyl D-aspartate receptors in endothelial and
smooth muscle cell lines. Arkansas Technical University, Junior Science and Humanities Symposium-Russellville, AR; April 2004. Received 4th place award. 40. Kazi R, Brown A, Chen H, Moursi M. Locating N-methyl D-aspartate receptors in endothelial and
smooth muscle cell lines. Army Sponsored National Junior Science and Humanities Symposium as a student observer-Baltimore, MD; May 2004. Received 4th place award. 41. Moursi M, Chen H, Brown A, Wu Y, Fitzgerald R, Qureshi I, Eidt J. Identification of N-Methyl-D-
Aspartate receptor in peripheral vascular smooth muscle cells and their role in homocysteine medicated cell replication. Read before the Association of VA Surgeons. Richmond, Virginia, April 2004. 42. Moursi M, Brown A, Eidt J. Saratin decreases platelet aggregation and homocysteine mediated
post carotid endarterectomy intimal hyperplasia. Read before the Collier Society. Nashville, Tennessee, September 2004. 43. Kazi R, Brown A, Chen H, Moursi M. Understanding the Physiological Pathway of Homocysteine.
U.S. Army, Navy, and Air Force sponsored 43rd National Junior Science & Humanities Symposium (JSHS), San Diego, 2005. Received 2nd place award. 44. Bledsoe SL, Barr J, Fitzgerald RF, Brown AT, Faas F, Breckenridge J, Eidt JF and Moursi MM.
The effects of pravastatin and clopidogrel on intimal hyperplasia in a rat model of carotid endarterectomy. 29th Annual Meeting of the Southern Association for Vascular Surgery, January 19-22, 2005, Marco Island, Florida 45. Ali A, Moursi M, Kalapatapu V, Bledsoe S, Ahmed A, Eidt J. Intermediate results of remote
superficial femoral artery endarterectomy with endografts. Read before the Association of VA Surgeons. Salt Lake City, Utah, March 2005. 46. Hongjiang C, Brown A, Zhang X, Faas F, Ercal N, Poirier L, Fitzgerald R, Breckenridge J, Eidt J, Moursi M. D-α and mixed-tocopherols decrease homocysteine mediated increases in intimal
hyperplasia following endarterectomy. Experimental Biology, March 31st -April 5th, 2005,
Washington, DC.
47. Brown A, Hongjiang C, Zhang X, Moursi M. Homocysteine induces NADPH oxidase expression
in rat vascular smooth muscle cells: Role of NMDA receptor and PKCε. 4th Conference on Hyperhomocysteinemia Saarland University, April 14th – 16th, 2005, Saarbruecken, Germany 48. Ali A, Moursi M, Bledsoe S, Kalapatapu V, Eidt J. Percutaneous isolated limb perfusion for
severe ischemia in non-revascularization candidates: Is this real or just fantasy? Read before the Society for Clinical Vascular Surgery. Coral Gables, Florida, March 2005. 49. Kalapatapu V, Satterfield L, Brown AT, Chen H, Ercal N, Price TO, Gao J, Ibrahim K, Moursi M.
Toradol effects on Post-Operative Intimal Hyperplasia in a Rat Carotid Endarterectomy Model. Founders’ Award Paper – Southern Association for Vascular Surgery. Phoenix, AZ January 18-21, 2006. 50. Brown AT, Chen H, Monaghan DT, Moursi MM. Homocysteine (HCys) induces apoptosis in rat
aorta endothelial cells (RAEC): Role of NMDA receptor and MAP kinase (MAPK). Experimental Biology, March 31- April 5, 2006, San Francisco, CA. 51. Hiltz WS, Bledsoe SL, Kirtley LD, Kirst CL, Eidt JL, Moursi M. Recognition and Repair of
Popliteal Artery Aneurysms. Southwestern Surgical Congress. Kauai, HI April 3 – 7, 2006. 52. Ali AT, Wright L, Van Husen R, Moursi M, Eidt JF. High Resolution Computed Tomography
Angiogram: Can it be used for both arterial and venous imaging? Society for Vascular Surgery. Philadelphia, PA June 1 – 4, 2006. 53. Eidt JF, Ali, A, Moursi MM. Incidence and Management of Complications of Arterial Closure
Devices. Veith Symposium, November 17-19, 2005, New York, NY. 54. Brown A, Luo S, Howard C, Eidt J, Moursi M. High resolution duplex visualization details
development of normal and exaggerated luminal stenosis following endarterectomy. Experimental Biology 2009, April 18-22, New Orleans, LA 55. Moursi M, Brown AT, Luo S, Culp WC. Microbubble Assisted Ultrasound Prevents Neointimal
Hyperplasia. The SVS 2009 Research Initiatives in Vascular Disease Conference. April 28, 2009, Washington, D.C. 56. Ali A, Kalapatapu K, Foteh K, Moursi M, Eidt J,. Partial Excision of Aortofemoral Bypass and
Reconstruction with Femoral Vein: Short Term Outcomes. Society for Clinical Vascular Surgery, March 7-10, 2010, Scottsdale, Arizona. 57. Wilensky J, Moursi M. A review of 26 lower extremity bypass grafts that maintined patency for over 10 years. Southwestern Surgical Congress, April 8, 2011, Ko Olina, Hawaii. Society for Clinical Vascular Surgery. March 18, 2011, Las Vegas, NV. 59. Ali A, Desikan S, Modrall G, Moursi M, Eidt J. Gracilis Muscle Flap for groin infections: under
Utilized by the Vascular Surgeons. Society for Clinical Vascular Surgery. March 18, 2011, Las Vegas, NV. 60. Shelton K, Ali A, Moursi M, Modrall G, Eidt J
Society for Clinical Vascular Surgery. March 18, 2011, Las Vegas, NV. PUBLICATIONS
1. Moursi MM, Luyckx BA, D’Alecy LG. The role of ethanol in diluents that protect mice from
2. Moursi MM, Van Wylen DL, D’Alecy LG. Regional blood flow changes in response to mildly
pressor doses of triglycyl desamino lysine and arginine vasopressin in the conscious dog. J Pharmacol Exp Ther 232:360-8, 1985. 3. Moursi MM, Rising CL, Zelenock GB, D’Alecy LG. Dextrose administration exacerbates acute
renal ischemic damage in anesthetized dogs. Arch Surg 122:790-4, 1987. 4. Moursi MM, D’Alecy LG. Depressor response during experimental portal hypertension in the
dog. Am J Physiol 251 (Heart Circ Physiol 20): H1188-H1194, 1986. 5. Frank RS, Moursi MM, Rodrazik RM, Zelenock GB, D’Alecy LG. Renal vasoconstriction and
transient declamp hypotension after infrarenal aortic occlusion: Role of plasma purine degradation products. J Vasc Surg 7:515-23, 1988. 6. Moursi MM, Facktor MA, Zelenock GB, D’Alecy LG. Delayed onset hypertension with infrarenal
aortic cross-clamping in dogs. J Surg Res 56:168-78, 1994. 7. Moursi MM, Facktor MA, Zelenock GB, D’Alecy LG. Systemic hypertension induced by aortic
cross-clamping: Detrimental effects of direct smooth muscle relaxation compared to ganglionic blockade. J Vasc Surg 4:707-16, 1994. 8. Greenfield LJ, Proctor MC, James EA, Abrams GD, Moursi MM. Staging of fixation and
retrievability of Greenfield filters. J Vasc Surg 20:744-50, 1994. 9. Moursi MM, Beebe HG, Messina LM, Welling TH, Stanley JC. Inhibition of aortic aneurysm
development in blotchy mice by beta adrenergic blockade independent of altered lysyl oxidase activity. J Vasc Surg 21:792-800, 1995. 10. Barone GW, Sailors DM, Eidt JF, Moursi MM, Williams ES, Barnes RW. Occlusion of vessels
with posterior plaques. J Am Col Surg 182:549-51, 1996. 11. Roberts JA, McFarland DR, Moursi MM, Thomas D, Harshfield D. Renal artery stenosis
secondary to atherosclerotic disease. J Ark Med Soc 93:101-2, 1996. 12. Matchett WJ, McFarland DR, Russell DK, Sailors DM, Moursi MM. Gadolinium as contrast for
digital subtraction angiography in an azotemic patient. Radiology 201:569-71, 1996. 13. Moursi MM. Hypertension, Pharmacological Therapy and Expansion Rates of Abdominal Aortic
Aneurysms. L’Information Cardiologique 21(22):397-407, 1997. 14. Southern FN, Cruz N Jr, Fink LM, Eidt JF, Moursi MM. Hyperhomocysteinemia Increases Intimal
Hyperplasia in a Rat Carotid Endarterectomy Model. J Vasc Surg 28(5):909-18, 1998. 15. Barone GW, Moursi MM, Eidt JF. Aortoiliac Vascular Disease in Younger Women: The Potential
for Delayed Diagnosis. The Female Patient 23:27-35, Oct. 1998. 16. Proctor MC, Greenfield LJ, Cho KJ, Moursi MM, James EA. Assessment of apparent vena caval
penetration by the Greenfield filter. J Endovasc Surg 5(3):251-8, 1998. 17. Taylor DW, Barnett HJM, Haynes RB et al, (ACE) Trial Collaborators*. Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid endarterectomy: A randomized, controlled
trial. Lancet 353:2179-84, 1999. *Nazarian S, Krisht A, Malik J, Skidmore G, Teo C, Barnes RW,
Barone GW, Boop W, Eidt JF, Gagne P, Moursi MM, Kennedy LA.
18. Drouilhet JC, West B, Williams K, Read RC, Moursi MM. Incisional Hernia after aortic surgery.
19. Eidt JF, Habibipour S, Saucedo JF, McKee J, Southern FN, Moursi MM, Barone GW, Talley JD.
Surgical Complications from Hemostatic Puncture Closure Devices. Am J Surg 178(6):511-16, 1999. 20. Matchett WJ, McFarland DR, Eidt JF, Moursi MM. Treatment of Blue Toe Syndrome with
intraarterial stents. JVIR 11:585-92, May 2000. 21. Read RC, Barnes RW, Eidt JF, Hauer-Jensen M, Moursi MM. Femorofemoral Arterial Bypass:
Subcutaneous or Preperitoneal. Vasc Surg 34(4):337-44, July/Aug 2000. 22. Drouilhet JC, Southern FN, Williams DK, Brown AT, Eidt JF, Moursi MM. Increased Intimal
Hyperplasia after Carotid Endarterectomy in Spontaneously Hypertensive Rats. Vasc Surg 35(1):11-18, 2001. 23. Hodge K, Yuen J, Moursi MM, Eidt JF. Critical Leg Ischemia Resulting From Interruption of
Collaterals by Harvest of the Rectus Abdominus Free Flap: Endovascular Salvage. Ann Plast Surg 45:427-30, 2000. 24. Cruz CP, Eidt JF, Drouilhet JC, Brown AT, Moursi MM. Saratin: (A Specific Inhibitor of Platelet
to Collagen Adhesion) Decreases Platelet Aggregation and Neointimal Hyperplasia in a Rat Carotid Endarterectomy Model. J Vasc Surg 34(4):724-30, 2001. 25. Smith TP, Cruz CP, Moursi MM, Eidt JF. Infectious Complications Resulting from Use of
Hemostatic Puncture Closure Devices. Am J Surg 182:658-662, 2001. 26. Smith TP, Cruz CP, Brown AT, Eidt JF, Moursi MM. Folate Supplementation Inhibits Intimal
Hyperplasia Induced by a High Homocysteine Diet in a Rat Carotid Endarterectomy Model. J Vasc Surg 34:474-81, 2001. 27. Southern FN, Eidt JF, Moursi MM, et al. Increasing Levels of Dietary Homocysteine with Carotid
Endarterectomy Produced Proportionate Increases in Plasma Homocysteine and Intimal Hyperplasia. Atherosclerosis 158:129-38, 2001. 28. Cruz CP, Drouilhet JC, Southern FN, Eidt JF, Barnes RW, Moursi MM. Abdominal Aortic
Aneurysm Repair. Vasc Surg 35(5):335-44, 2001. 29. Culp WC, McCowan TC, James CA, Marchett WJ, Schmidt MB, Moursi MM, Roberson P.
Microbubble Augmented Ultrasound Declotting of Thrombosed Dialysis Grafts: An Ultrasound Dosage Study in Dogs. J Vasc Interv Radiol 14:343-47, 2003. 30. Smith TP, AlShafie TA, Cruz CP, Fan CY, Brown AT, Wang y, Eidt JF, Moursi MM. Saratin, an
Inhibitor of Collagen-Platelet Interaction, Decreases Venous Anastomotic Intimal Hyperplasia in a Canine Dialysis Access Model. Vasc and Endovasc Surg 37:259-269, 2003. 31. Brown AT, Smith TP, Cruz CP, Poirer LA, Simmons D, Williams DK, Wang Y, Eidt JF, Moursi
MM. Intimal hyperplasia following carotid endarterectomy in an insulin-resistant rat model.
Metabolism 52:834-839, 2003.
32. Cruz CP, Eidt JF, Capps C, Kirtley L, Moursi MM. “Major Lower Extremity Amputations at a VA
Hospital: A Seven Year Experience.” Am J Surg 186:449-54, 2003. 33. Cruz CP, Alshafie T, Eidt JF, Williams DK, Moursi MM. Correlation Between Preoperative and
Postoperative Duplex Vein Measurements of the Greater Saphenous Vein Used for Infrainguinal Arterial Reconstruction. Vasc and Endovasc Surg 38:57-62, 2004. 34. Davis JA, Brown AT, Chen H, Wang YF, Poirier L, Eidt JF, Cruz, CP, Moursi MM. Cigarette
Smoke Increases Intimal Hyperplasia and Homocysteine in a Rat Carotid Endarterectomy. J Surg Res 121:69-75, 2004. 35. Brown AT, Chen H, Davis JA, Qureshi I, Cruz CP, Poirier LA, Eidt JF, Moursi MM. Plasma
homocysteine measurements after carotid artery manipulation and clamping in a rat CEA model. J Vasc Surg 40:796-802, 2004. 36. Davis JA, Brown AT, Alshafie T, Poirier LA, Cruz CP, Wang Y, Eidt JF, Moursi MM. Saratin (an
inhibitor of platelet-collagen interaction) decreases platelet aggregation and homocysteine mediated post-carotid endarterectomy intimal hyperplasia in a dose dependent manner. Am J Surg 188:778-785, 2004. 37. Bledsoe SL, Davis JA, Brown AT, Chen H, Eidt JF, Moursi MM. Effect of clopidogrel on platelet
aggregation and intimal hyperplasia following carotid endarterectomy. Vascular 13: 43-49, 2005. 38. Hongjiang C, Fitzgerald R, Brown AT, Qureshi I, Breckenridge J, Kazi R, Wang YF, Wu Y, Zhang X, Mukunyadzi P, Eidt J, Moursi MM. Identification of a homocysteine receptor in the peripheral
endothelium and its role in proliferation. Journal of Vascular Surgery 41: 853-60, 2005.
39. Ali A, Moursi M, Bledsoe S, Kalapatapu V, Eidt J. Percutaneous isolated limb perfusion for
severe ischemia in non-revascularization candidates: Is this real or just fantasy? Vasc and Endovasc Surg 39:491-499, 2005. 40. Qureshi I, Chen H, Brown AT, Fitzgerald R, Wang YF, Zhang X, Breckenridge J, Kazi R, Crocker AJ, Cooke J, Stühlinger MC, Lin K, Eidt JF and MM Moursi. Homocysteine-induced vascular
dysregulation is mediated by the NMDA Receptor. Vasc Med 10(3) :215-23, 2005.
41. Bledsoe SL, Barr JC, Fitzgerald JT, Brown AT, Faas FH, Eidt JF, Moursi MM. Pravastatin and
clopidogrel combined inhibit intimal hyperplasia in a rat carotid endarterectomy model. Vasc Endovascular Surg. Jan-Feb;40(1):49-57, 2006. 42. Kalapatapu VR, Ali AT, Masroor F, Moursi MM, Eidt JF. Techniques for Managing Complications
of Arterial Closure Devices. Vasc Endovasc Surg 40:399-408, 2006. 43. José AD, Brendan TC, Moursi MM, Cristiano B, Evan RK, Richard JJ, and Samuel DS,. Delayed
manifestation of abdominal aortic stenosis in a child presenting 10 years after blunt abdominal trauma. Journal of Vascular Surgery 44 (5): 1104-1106, 2006. 44. AhsanTA, Kalapatapu V, Ahmed O, Moursi MM, Eidt JF. Remote Superficial Femoral Artery
Endarterectomy: Early Results for TASC D Lesions in Patients with Severe Ischemia. Vasc Endovasc Surg 41-4, 2007. 45. Kalapatapu VR, Satterfield L, Brown AT, Chen H, Ercal N, Price TO, Gao J, Moursi MM. The
effects of Toradol on postoperative intimal hyperplasia in a rat carotid endarterectomy model: Laboratory research. Vasc Endovasc Surg 41-5, 2007. 46. Kalapatapu VR, Shelton KR, Ali AT, Moursi MM, Eidt JF. Pseudoaneurysm: a review. Curr
Treat Options Cardiovasc Med, 173-83, 2008 Apr; 10(2). 47. Ali AT, Mcleod N, Kalapatapu VR, Moursi MM, Eidt JF. Staging the neoaortoiliac system:
Feasibility and short-term outcomes. Journal of Vascular Surgery, 1-7, 2008. 48. Nyalala J, Luo S, Campbell D, Brown, Moursi MM. The effects of Acarbose treatment on intimal
hyperplasia in a rat carotid endarterectomy model of diet-induced insulin resistance. Vasc and Endovasc Surg 44:560-567, 2010. a Radial Artery Grafts vs Saphenous Vein Grafts in Coronary Artery Bypass Surgery.2011. 50. Nyalala JO, Brown AT, Luo S, Deng H, Moursi MM
Vasc Endovascular Surg. 45(8):720-6, 2011. Book Chapters
1. Moursi MM, Stanley JC. Surgical Treatment of Ruptured Infrarenal Aortic Aneurysms. Ernst CB,
Stanley JC (eds), Current Therapy in Vascular Surgery, Vol. 3. St, Louis, Missouri, Mosby-Yearbook. 2. Moursi MM. Abdominal Aortic Aneurysm. McKellar DP, Reiling RB, Eiseman B (eds), Prognosis
and Outcome Expectancy of Surgical Disease, St. Louis, Missouri, Quality Medical Publishing, Inc. 3. Moursi MM. Blunt Arterial Injuries to the Knee. Ernest CB, Stanley JC (eds). Current Therapy in
Vascular Surgery, Vol. 4. St. Louis, Missouri, Mosby-Yearbook. 4. Moursi MM. Acute Stroke after Carotid Endarterectomy. Upchurch G, Henke P (eds). Clinical
Scenarios of Vascular Surgery, Philadelphia, PA, Lippincott, Williams and Wilkins Publishing. 5. Moursi MM. Graft Thrombosis. Zelenock GB, Huber TS, Messina LM, Lumsden AB, Moneta GL
(eds). Mastery of Vascular and Endovascular Surgery. Philadelphia, PA, Lippincott, Williams & Wilkins Publishing. 6. Moursi MM, Eidt JF. Direct Reconstruction of the Aortic Arch Branches. Mastery of Surgery,
Fifth Edition; Fischer J ed., Lippincott, Williams, and Wilkins. 7. Alvord L, Mock C., Sayyed K., Moursi M, Jaffar M. Cultural Adaptability: Intercultural
Techniques. Communication & Professionalism Competencies: A Guide for Surgeons. Woodbury, CT, Cine-Med, Inc. INVITED LECTURES
Moursi MM. Renal Vascular Hypertension Techniques in Operative Management. Read before
the First Arab Meeting of Angiology & Vascular Surgery. Hurghada, Red Sea, Egypt. June 1998.
Moursi MM. Carotid Endarterectomy Under Regional Anesthesia. Read before the First Arab
Meeting of Angiology & Vascular Surgery. Hurghada, Red Sea, Egypt. June 1998.
POSTDOCTURAL FELLOWS

Hongjiang Chen, M.D.

Source: http://surgery.uams.edu/upload/docs/Surgery%20Dept/Moursis%20CV.pdf